US-BASED Fluidigm Corp yesterday opened its first overseas biochip manufacturing plant in Singapore - and plans to invest S$40 million here to ramp up output over the next five years.
US-BASED Fluidigm Corp yesterday opened its first overseas biochip manufacturing plant in Singapore - and plans to invest S$40 million here to ramp up output over the next five years.
